NEW YORK, July 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ITRM, BLIN, TATT, VEON, and SRNE.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  • ITRM: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ITRM&prnumber=070220216
  • BLIN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=BLIN&prnumber=070220216
  • TATT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=TATT&prnumber=070220216
  • VEON: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=VEON&prnumber=070220216
  • SRNE: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SRNE&prnumber=070220216

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-iterum-therapeutics-bridgeline-digital-tat-technologies-veon-or-sorrento-therapeutics-301325033.html

SOURCE InvestorsObserver